DUSA: Enrollment for Ph IIb Trial of Levulan(R) Photodynamic
Trading Markets (press release), CA - Mar 31, 2008
DUSA Pharmaceuticals, Inc. (DUSA) announced that the acne Phase IIb trial has achieved its goal of 260 participants, thus completing enrollment.

Leave a Reply